- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04117061
Optimizing the Diagnosis of Acute Appendicitis (OPTIMA)
3. oktober 2019 opdateret af: Tomas Poskus, Vilnius University
Optimizing the Diagnosis of Acute Appendicitis - Open, Randomized, Parallel Groups, Prospective Clinical Trial
Aim of the study: to identify the signs of acute appendicitis delta signs - clinical, laboratory or ultrasound signs, whose change (delta) would allow to identify or deny the diagnosis of acute appendicitis without a computed tomography examination and thus to lower computed tomography rates.
Studieoversigt
Status
Ukendt
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This study consists of two parts:
- In the first part investigators enroll all patients (except pregnant) that are refered to Vilnius University Hospital Santaros clinics with suspected acute appendicitis in order to get cohort data. All patient get primary clinical evaluation, laboratory tests (WBC, CRP) an ultrasound examination.
- After primary evaluation if final diagnosis could not be made, and investigator still suspect acute appendicitis, participant is included in to randomised study part.
- Randomised sudy part has two arms: control and observation groups.
- Control group get the traditional diagnostic path - is refered to CT scan examination.
- Observation group get repeated evaluation after 8-12 hours and only than is diagnosis stays unclear, patient gets a CT scan.
- All patient are contacted after 30 days after visit to our hospital, to get information about their health status and possible additional visits to other hospitals or operations.
Undersøgelsestype
Interventionel
Tilmelding (Forventet)
200
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Vilnius, Litauen
- Rekruttering
- Faculty of medicine, Institue of clinical medicine, Clinic of gastroenterology, nephrourology and surgery
-
Kontakt:
- Tomas Poskus, Professor
- Telefonnummer: +37068678893
- E-mail: tomas.poskus@santa.lt
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Patient with the symptoms of acute appendicitis: pain in the right lower quadrant, pain migration from epigastrium to right lower quadrant, nausea, rebound pain, elevated temperature.
Exclusion Criteria for randomized part:
- Pregnant patient.
Inclusion Criteria for randomized part:
- After primary clinical, laboratory and ultrasound examination diagnosis of acute appendicitis could not be confirmed or excluded.
- No other gynecological, urological ir gastroenterological pathology is confirmed.
Exclusion Criteria for randomized part:
- Clinical symptoms lasts for longer than 48 hours
- Signs of peritonitis
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Diagnostisk
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Ingen indgriben: Control
Patient gets usual diagnostic path: after inconclusive ultrasound is refered to CT scan.
|
|
Aktiv komparator: Observation
Patient after inconclusive primary evaluation is observed in emergency room for 8-12 hours and after the clinical evaluation, laboratory results and ultrasound examination is repeated.
|
Patient after primary investigation is observed for 8-12 hours, (instead of being send directly to CT scan), after observation repeated clinical evaluation, laboratory tests and ultrasound examination are done , if final diagnosis stays unclear the patient is refered to CT scan.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Reduction of the CT scans number
Tidsramme: 24 hours
|
when performing alternative diagnostic protocol, that includes patient observation for short period we expect to reduce a number of CT scans performed, for the patients with suspected acute appendicitis.
|
24 hours
|
Negative appendectomy rate
Tidsramme: 30 days
|
We expect the negative appendectomy rate will will not increase while using alternative diagnostic protocol that includes patient observation.
|
30 days
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Delta marker White blood cell count
Tidsramme: 12 hours
|
The changes in white blood cell count over the time that might show higher or lower probability of possible acute appendicitis.
|
12 hours
|
Delta marker CRP count
Tidsramme: 12 hours
|
The changes CRP level over the time that might show higher or lower probability of possible acute appendicitis.
|
12 hours
|
Delta marker Alvarado acute appendicitis risk evaluation score
Tidsramme: 12 hours
|
Delta marker Alvarado acute appendicitis risk evaluation score Tha changes in score over the time that might show higher or lower probability of possible acute appendicitis.
Scale ranges decribe a prediction of having acute appendicitis: 1-4 33 % of having appendicitis, 5-6 66 % of hanving, 7-10 93 % of having appendicitis.
|
12 hours
|
Delta marker changes in ultrasound results
Tidsramme: 12 hours
|
The changes in ultrasound findings over the time may progress and influence investigator to change opinion about the concusion.
Repeated ultrasound diagnosis might change from unequivocal to acute apendicitis (and CT scan can be avoided then).
We do use structured conclusions of the ultrasound exam, that might be: accute appendicitis; apendix visualised but changes are equivocal; apendix visualised uninflamed; apendix not visualised, but there are secondary findings; apendix not visualised and there is no secondary findings.
We are going to measure the change in final ultrasound diagnosis over the time.
|
12 hours
|
'Appendicitis Inflammatory Response (AIR) Score'
Tidsramme: 12 hours
|
'Appendicitis Inflammatory Response (AIR) Score') evaluates the risk for acute appendicitis.
scale ranges are: 0-4 low probability outpatient follow up, 5-8 inermediate probability in hospital observation, 9-12 high probability, surgical treatment..
|
12 hours
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Tomas Poskus, Professor, Vilnius University, Faculty of medicine, Institute of clinical medicine
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
1. december 2018
Primær færdiggørelse (Forventet)
1. januar 2021
Studieafslutning (Forventet)
1. maj 2021
Datoer for studieregistrering
Først indsendt
29. juni 2019
Først indsendt, der opfyldte QC-kriterier
3. oktober 2019
Først opslået (Faktiske)
7. oktober 2019
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
7. oktober 2019
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
3. oktober 2019
Sidst verificeret
1. oktober 2019
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- UADO-1
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
IPD-planbeskrivelse
There are no future intensions make IPD available.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Observation
-
Centre Hospitalier Régional d'OrléansAfsluttet
-
Universidad Autonoma de MadridUkendt
-
University of BergenEuropean Society of Intensive Care MedicineAfsluttetKritisk sygdom | Alderdom; Svaghed | OverlevelseNorge
-
Peking University Third HospitalRekruttering
-
Changhua Christian HospitalDa-Yeh UniversityIkke rekrutterer endnuHjerte-kar-sygdomme
-
King's College LondonIkke rekrutterer endnuMyokardieinfarkt | Hjertesygdomme | Hjerte-kar-sygdomme | Hjertefejl | Betændelse | Myokarditis | Perikarditis
-
Iain BressendorffDitte Hansen MD PhD; Casper Rydahl MD; Anders Nordholm MD PhD; Eva Gravesen...Ikke rekrutterer endnuNefrotisk syndrom | Minimal Change Disease | Membranøs nefropati | Primær Fokal Segmental Glomerulosklerose
-
MultiCare Health System Research InstituteRekruttering
-
Royal Marsden NHS Foundation TrustIkke rekrutterer endnu
-
Second Affiliated Hospital, School of Medicine,...Jinhua People's Hospital; Jinhua Municipal Central Hospital; Yiwu Central... og andre samarbejdspartnereRekruttering